A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

about

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

Item

http://www.wikidata.org/entity/Q48103048

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

@en

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

@nl

type

Item

label

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

@en

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

@nl

prefLabel

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

@en

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

@nl

P1476

A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity

@en

P2093

Andrea Altieri

http://www.w3.org/2001/XMLSchema#string

Dmitry S Belov

http://www.w3.org/2001/XMLSchema#string

Evgeny R Lukyanenko

http://www.w3.org/2001/XMLSchema#string

Giulia Maietta

http://www.w3.org/2001/XMLSchema#string

Grigory M Belov

http://www.w3.org/2001/XMLSchema#string

Ivan A Andreev

http://www.w3.org/2001/XMLSchema#string

Maria Letizia Barreca

http://www.w3.org/2001/XMLSchema#string

Nina K Ratmanova

http://www.w3.org/2001/XMLSchema#string

Saioa R Elezgarai

http://www.w3.org/2001/XMLSchema#string

Silvia Biggi

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy

Transmission dynamics and epidemiology of BSE in British cattle

Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes

Novel proteinaceous infectious particles cause scrapie

A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein.

The public health impact of prion diseases.

A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.

Structure-brain exposure relationships.

Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.

CNS drug design: balancing physicochemical properties for optimal brain exposure.

P304

1286-1292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201700302

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emiliano Biasini

Alexander V Kurkin

Claudia Stincardini

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28722340

http://www.w3.org/2001/XMLSchema#string

P921

Prion protein family